Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Dyskeratosis congenita (DC) is a genetic disorder of defective tissue maintenance and cancer predisposition caused by short telomeres and impaired stem cell function. Telomerase mutations are thought to precipitate DC by reducing either the catalytic activity or the overall levels of the telomerase complex. However, the underlying genetic mutations and the mechanisms of telomere shortening remain unknown for as many as 50% of DC patients, who lack mutations in genes controlling telomere homeostasis. Here, we show that disruption of telomerase trafficking accounts for unknown cases of DC. We identify DC patients with missense mutations in TCAB1, a telomerase holoenzyme protein that facilitates trafficking of telomerase to Cajal bodies. Compound heterozygous mutations in TCAB1 disrupt telomerase localization to Cajal bodies, resulting in misdirection of telomerase RNA to nucleoli, which prevents telomerase from elongating telomeres. Our findings establish telomerase mislocalization as a novel cause of DC, and suggest that telomerase trafficking defects may contribute more broadly to the pathogenesis of telomere-related disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Eight mutant genes have been identified in dyskeratosis congenita9,38,39,60–64, and all of them encode telomerase or telomere protein components (summarized in Table 1).”
From The telomere syndromes (2012) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Shelterin mutations have been found in some cases of aplastic anemia and dyskeratosis congenita (Savage et al., 2008; Walne et al., 2008; Zhong et al., 2011).”
From The Hallmarks of Aging (2013) · cites this paper as Zhong et al., 2011
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MutationTaster evaluates disease-causing potential of sequence alterations
Schwarz, J. M., Rödelsperger, C., Schuelke, M., & Seelow, D. (2010) · Nature Methods · doi:10.1038/nmeth0810-575 · Cited by 2,975 · cited 1×
“Each diseaseassociated mutation in TCAB1 occurs in a highly conserved residue and was predicted to alter protein function (Schwarz et al. 2010).”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 1×
“Telomere shortening in settings of insufficient telomerase limits tissue renewal by impairing the function of tissue stem cells and progenitor cells, suggesting that DC is a stem cell disease (Lee et al. 1998).”
BackgroundA telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894 · cited 1×
“In patientswith germlinemutations in genes controlling telomere homeostasis, telomere shortening causes a range of disease phenotypes, including dyskeratosis congenita (DC), pulmonary fibrosis, aplastic anemia, and cancer predisposition (Mitchell et al. 1999; Vulliamy et al. 2004; Yamaguchi et al. 2005; Armanios et al…”
BackgroundNon-coding RNAs: lessons from the small nuclear and small nucleolar RNAs
Matera, A. G., Terns, R. M., & Terns, M. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2124 · Cited by 877
Regulation of Telomerase by Telomeric Proteins
Smogorzewska, A., & de Lange, T. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.160049 · Cited by 798
Linking functional decline of telomeres, mitochondria and stem cells during ageing
Sahin, E., & DePinho, R. A. (2010) · Nature · doi:10.1038/nature08982 · Cited by 759
Calado, R. T., & Young, N. S. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0903373 · Cited by 754
Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042980 · Cited by 723
Cited by
Items 101–200 of 262
Klaric, J. A., Wüst, S., & Panier, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.668821 · Cited by 49
Non-canonical roles of canonical telomere binding proteins in cancers
Akıncılar, S. C., Chan, C. H. T., Ng, Q. F., Fidan, K., & Tergaonkar, V. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03783-0 · Cited by 47
Fernandes, S. G., Dsouza, R., & Khattar, E. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103633 · Cited by 47
Telomere biology and translational research
Mason, P. J., & Perdigones, N. (2013) · Translational research · doi:10.1016/j.trsl.2013.08.009 · Cited by 45
TCAB1: a potential target for diagnosis and therapy of head and neck carcinomas
Sun, C., Luo, X., Gou, Y., Hu, L., Wang, K., Li, C., Xiang, Z., Zhang, P., Kong, X., Zhang, C., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-180 · Cited by 41
Telomere-Regulating Genes and the Telomere Interactome in Familial Cancers
Robles‐Espinoza, C. D., Velasco‐Herrera, M. D. C., Hayward, N. K., & Adams, D. J. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0305 · Cited by 46
Towards an understanding of regulating Cajal body activity by protein modification
Hebert, M. D., & Poole, A. R. (2016) · RNA Biology · doi:10.1080/15476286.2016.1243649 · Cited by 43
Bergstrand, S., Böhm, S., Malmgren, H., Norberg, A., Sundin, M., Nordgren, A., & Farnebo, M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2421-4 · Cited by 39
Dey, A., & Chakrabarti, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020333 · Cited by 47
Fan, H., Chang, F.-W., Tsai, J., Lin, K., Chen, C., Lin, S., Liu, C.-A., & Harn, H. (2021) · Life · doi:10.3390/life11121405 · Cited by 46
Small Cajal body-associated RNA 2 (scaRNA2) regulates DNA repair pathway choice by inhibiting DNA-PK
Bergstrand, S., O’Brien, E. M., Coucoravas, C., Hroššová, D., Peirasmaki, D., Schmidli, S., Dhanjal, S., Pederiva, C., Siggens, L., Mortusewicz, O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28646-5 · Cited by 47
TCAB1 prevents nucleolar accumulation of the telomerase RNA to facilitate telomerase assembly
Klump, B. M., Perez, G. I., Patrick, E. M., Adams-Boone, K., Cohen, S. B., Li, H., Yu, K., & Schmidt, J. C. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112577 · Cited by 42
Understanding telomere diseases through analysis of patient-derived iPS cells
Batista, L. F. Z., & Artandi, S. E. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.07.006 · Cited by 36
Self-citationThe relationship between DNA methylation and telomere length in dyskeratosis congenita
Gadalla, S. M., Katki, H. A., Shebl, F. M., Giri, N., Alter, B. P., & Savage, S. A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00755.x · Cited by 32
Self-citationClinical Correlates and Treatment Outcomes for Patients With Short Telomere Syndromes
Mangaonkar, A. A., Ferrer, A., Vairo, F. P. E., Cousin, M. A., Kuisle, R. J., Klee, E. W., Kennedy, C. C., Peters, S. G., Scott, J. P., Utz, J. P., et al. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.05.015 · Cited by 33
Inherited bone marrow failure syndromes in 2012
Sakaguchi, H., Nakanishi, K., & Kojima, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1249-9 · Cited by 37
Akt regulates TPP 1 homodimerization and telomere protection
Han, X., Liu, D., Zhang, Y., Li, Y., Lu, W., Chen, J., & Songyang, Z. (2013) · Aging Cell · doi:10.1111/acel.12137 · Cited by 35
Life and Death of Yeast Telomerase RNA
Vasianovich, Y., & Wellinger, R. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.01.013 · Cited by 31
Sun, Y., Cao, L., Sheng, X., Chen, J., Zhou, Y., Yang, C., Deng, T., Ma, H., Feng, P., Liu, J., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.162 · Cited by 34
Hedström, E., Pederiva, C., Farnebo, J., Nodin, B., Jirström, K., Brennan, D. J., & Farnebo, M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.250 · Cited by 32
Jeon, P., Ham, H.-J., Park, S., & Lee, J. (2022) · Cells · doi:10.3390/cells11132063 · Cited by 34
Rackley, S., Pao, M., Seratti, G. F., Giri, N., Rasimas, J. J., Alter, B. P., & Savage, S. A. (2012) · Psychosomatics · doi:10.1016/j.psym.2011.09.003 · Cited by 29
Self-citationStaněk, D. (2023) · Nucleus · doi:10.1080/19491034.2023.2256036 · Cited by 30
Zeng, X., Thumati, N. R., Fleisig, H. B., Hukezalie, K. R., Savage, S. A., Giri, N., Alter, B. P., & Wong, J. M. Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr504 · Cited by 32
Self-citationNopp140-mediated concentration of telomerase in Cajal bodies regulates telomere length
Bizarro, J., Bhardwaj, A., Smith, S. H., & Meier, U. T. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e19-08-0429 · Cited by 28
Telomerase and telomere biology in hematological diseases: A new therapeutic target
Allegra, A., Innao, V., Penna, G., Gerace, D. G., Allegra, A. G., & Musolino, C. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.02.002 · Cited by 39
Carrillo, J., Martínez, P., Solera, J., Moratilla, C., González, A., Manguán-García, C., Aymerich, M., Canal, L., Campo, M. D., Dapena, J. L., et al. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.05.008 · Cited by 30
Richard, M. A., Lupo, P. J., Morton, L. M., Yasui, Y., Sapkota, Y., Arnold, M., Aubert, G., Neglia, J. P., Turcotte, L. M., Leisenring, W. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228887 · Cited by 29
Novel variants in Nordic patients referred for genetic testing of telomere-related disorders
Norberg, A., Rosén, A., Raaschou‐Jensen, K., Kjeldsen, L., Moilanen, J. S., Paulsson-Karlsson, Y., Baliakas, P., Lohi, O., Ahmed, A. B., Kittang, A. O., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0112-8 · Cited by 27
Regulation of human telomerase RNA biogenesis and localization
Jian, Q., & Autexier, C. (2020) · RNA Biology · doi:10.1080/15476286.2020.1809196 · Cited by 34
Buemi, V., Schillaci, O., Santorsola, M., Bonazza, D., Broccia, P. V., Zappone, A., Bottin, C., Dell’Omo, G., Kengne, S., Cacchione, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29907-z · Cited by 26
Zheng, Z., Lin, F., Zhao, B., Chen, G., Wei, C., Chen, X., Nie, R., Zhang, R., Zhao, Z., Zhou, Z., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02223-4 · Cited by 26
The progression of the ClinGen gene clinical validity classification over time
McGlaughon, J., Goldstein, J., Thaxton, C., Hemphill, S. E., & Berg, J. S. (2018) · Human Mutation · doi:10.1002/humu.23604 · Cited by 24
Telomere Maintenance and the cGAS-STING Pathway in Cancer
Ebata, H., Loo, T. M., & Takahashi, A. (2022) · Cells · doi:10.3390/cells11121958 · Cited by 29
Garvin, S., Tiefenböck, K., Farnebo, L., Thunell, L. K., Farnebo, M., & Roberg, K. B. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.10.003 · Cited by 24
Lee, J. H., Jeong, S. A., Khadka, P., Hong, J., & Chung, I. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv844 · Cited by 32
Rassoolzadeh, H., Böhm, S., Hedström, E., Gad, H., Helleday, T., Henriksson, S., & Farnebo, M. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.172 · Cited by 26
Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report
Ratnasamy, V., Suganthan, N., Sirisena, N. D., Grüning, N., Brandau, O., Kumanan, T., Dagnall, C. L., McReynolds, L. J., Savage, S. A., & Dissanayake, V. H. W. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0584-y · Cited by 27
Self-citationVieri, M., Brümmendorf, T. H., & Beier, F. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101282 · Cited by 26
Coucoravas, C., Dhanjal, S., Henriksson, S., Böhm, S., & Farnebo, M. (2016) · RNA Biology · doi:10.1080/15476286.2016.1243647 · Cited by 24
Dysfunctional telomeres and hematological disorders
Fiorini, E., Santoni, A., & Colla, S. (2018) · Differentiation · doi:10.1016/j.diff.2018.01.001 · Cited by 26
Telomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
Ibáñez-Cabellos, J. S., Seco-Cervera, M., Picher-Latorre, C., Pérez-Machado, G., García‐Giménez, J. L., & Pallardó, F. V. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118845 · Cited by 25
Yamaguchi, H., Sakaguchi, H., Yoshida, K., Yabe, M., Yabe, H., Okuno, Y., Muramatsu, H., Takahashi, Y., Yui, S., Shiraishi, Y., et al. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1861-6 · Cited by 22
Dynamics of Human Telomerase Holoenzyme Assembly and Subunit Exchange across the Cell Cycle
Vogan, J. M., & Collins, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.659359 · Cited by 26
Limbal stem cell deficiency in patients with inherited stem cell disorder of dyskeratosis congenita
Aslan, D., Akata, R. F., Holme, H., Vulliamy, T., & Dokal, I. S. (2012) · International Ophthalmology · doi:10.1007/s10792-012-9611-8 · Cited by 20
The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
Silwal‐Pandit, L., Russnes, H. G., Borgen, E., Skarpeteig, V., Vollan, H. K. M., Schlichting, E., Kåresen, R., Naume, B., Børresen‐Dale, A., Farnebo, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139965 · Cited by 20
Bizarro, J., & Meier, U. T. (2017) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.314 · Cited by 24
Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases
Wang, J. Y., & Young, L. R. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0557tr · Cited by 20
Rolles, B., Tometten, M., Meyer, R., Kirschner, M., Beier, F., & Brümmendorf, T. H. (2024) · Transfusion Medicine and Hemotherapy · doi:10.1159/000540109 · Cited by 18
Telomerase regulation: A key to inhibition?
Gómez, D. L. M., Fariña, H. G., & Gomez, D. E. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2104 · Cited by 22
A role for sister telomere cohesion in telomere elongation by telomerase
Houghtaling, B. R., Canudas, S., & Smith, S. H. (2012) · Cell Cycle · doi:10.4161/cc.11.1.18633 · Cited by 21
Telomere Dysfunction and Hematologic Disorders
Paiva, R. M. A., & Calado, R. T. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00006-2 · Cited by 20
Chu, T. W., MacNeil, D., & Autexier, C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714782 · Cited by 20
Assani, G., Xiong, Y., Zhou, F., & Zhou, Y. (2018) · Oncotarget · doi:10.18632/oncotarget.26150 · Cited by 18
Telomere dynamics and reproduction
Robinson, L. G., Kalmbach, K., Sumerfield, O., Nomani, W., Wang, F., Liu, L., & Keefe, D. L. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.11.012 · Cited by 20
Gardano, L., Holland, L., Oulton, R., Bihan, T. L., & Harrington, L. A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1243 · Cited by 19
Shao, Y., Feng, S., Huang, J., Huo, J., You, Y., & Zheng, Y. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0549-1 · Cited by 17
RNF8 ubiquitinates RecQL4 and promotes its dissociation from DNA double strand breaks
Tan, Q., Niu, K., Zhu, Y., Chen, Z., Li, Y., Li, M., Wei, D., Balajee, A. S., Fang, H., & Zhao, Y. (2021) · Oncogenesis · doi:10.1038/s41389-021-00315-0 · Cited by 20
Wang, J., Dai, M., Xing, X., Wang, X., Qin, X., Huang, T., Fang, Z., Fan, Y., & Xu, D. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13324 · Cited by 19
Inherited Predispositions to Myeloid Neoplasms: Pathogenesis and Clinical Implications
Liu, Y.-C., Eldomery, M. K., Maciaszek, J. L., & Klco, J. M. (2025) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-111523-023420 · Cited by 16
Bergstrand, S., O’Brien, E. M., & Farnebo, M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00051 · Cited by 20
Overexpression of WDR 79 in non‐small cell lung cancer is linked to tumour progression
Sun, Y., Yang, C., Chen, J., Song, X., Li, Z., Duan, M., Li, J., Hu, X., Wu, K., Yan, G., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12759 · Cited by 16
Wang, K., Ge, Y., Ni, C., Cui, B., Du, J., Zhang, B., Hu, X., Chen, J., Xiao, L., Sun, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03156-3 · Cited by 17
Inherited bone marrow failure syndromes
Dokal, I. S. (2011) · Journal of Hematopathology · doi:10.1007/s12308-011-0089-5 · Cited by 15
Rassoolzadeh, H., Coucoravas, C., & Farnebo, M. (2015) · Nucleus · doi:10.1080/19491034.2015.1106675 · Cited by 17
New primary immunodeficiency diseases: context and future
Yu, J. E., Orange, J. S., & Demirdağ, Y. Y. (2018) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000699 · Cited by 15
Haploinsufficiency and telomere length homeostasis
Harrington, L. A. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.11.004 · Cited by 17
Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita
Elmahadi, S., Muramatsu, H., & Kojima, S. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000290 · Cited by 17
The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset
Gadelha, R. B., Machado, C. B., Pessoa, F. M. C. D. P., Pantoja, L. D. C., Barreto, I. V., Ribeiro, R. M., de Moraes, M. O., de Moraes, M. E. A., Khayat, A. S., & Moreira-Nunes, C. A. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44110372 · Cited by 15
Polygenic modifiers impact penetrance and expressivity in telomere biology disorders
Poeschla, M., Arora, U. P., Walne, A. J., McReynolds, L. J., Niewisch, M. R., Giri, N., Zeigler, L. P., Gusev, A., Machiela, M. J., Tummala, H., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191107 · Cited by 14
Self-citationHartwig, F. P., & Collares, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.03.003 · Cited by 11
Yuan, X., Cao, L., Hu, Y., Bao, F., Wang, Z.-T., Cao, J., Yuan, P., Lv, W., & Hu, J. (2017) · Tumor Biology · doi:10.1177/1010428317694309 · Cited by 13
Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling
Ly, H. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i10.89 · Cited by 12
The Epigenetic Regulation of Telomere Maintenance in Aging
Shekhidem, H. A., & Atzmon, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811060-7.00005-x · Cited by 16
Previously unreported WRAP53 gene variants in a patient with dyskeratosis congenita
Brailovski, E., Tsui, H., Chen, Y., Velsher, L., Liu, J., & Buckstein, R. J. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04678-7 · Cited by 11
Structure and Interactions of the CS Domain of Human H/ACA RNP Assembly Protein Shq1
Singh, M., Wang, Z., Cascio, D., & Feigon, J. F. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.12.012 · Cited by 13
RIOK2 transcriptionally regulates TRiC and dyskerin complexes to prevent telomere shortening
Ghosh, S., Nguyen, M. T., Choi, H. E., Stahl, M. F., Kühn, A. L., der Auwera, S. V., Grabe, H. J., Völzke, H., Homuth, G., Myers, S. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51336-3 · Cited by 15
[Telomerase and telomere: their structure and dynamics in health and disease].
Gómez, D. L. M., Armando, R. G., Fariña, H. G., & Gomez, D. E. (2014) · PubMed · Cited by 11
Live-cell imaging of budding yeast telomerase RNA and TERRA
Laprade, H., Lalonde, M., Guérit, D., & Chartrand, P. (2016) · Methods · doi:10.1016/j.ymeth.2016.07.014 · Cited by 9
Shepelev, N. M., Донцова, О. А., & Rubtsova, M. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055027 · Cited by 10
Wood, A. M., Garza-Gongora, A. G., & Kosak, S. T. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.01.003 · Cited by 10
Regulatory Effects of WRAP53 on Radiosensitivity of Laryngeal Squamous Cell Carcinoma Cells
Qiu, H., Zhao, D.-Y., Yuan, L.-M., Zhang, G., & Xie, C. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.7.2975 · Cited by 9
Inherited Bone Marrow Failure Syndromes
Canham, L. E., & de Jong, J. L. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00131-1 · Cited by 10
Nelson, N. E., Feurstein, S. K., Niaz, A., Truong, J. Q., Holien, J. K., Lucas, S. E. M., Fairfax, K. A., Dickinson, J. L., & Bryan, T. M. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.11.021 · Cited by 11
Dyskeratosis Congenita and the Telomere Biology Disorders
Dodson, L. M., & Bertuch, A. A. (2018) · Pediatric oncology · doi:10.1007/978-3-319-61421-2_6 · Cited by 8
How RNAi machinery enters the world of telomerase
Laudadio, I., Carissimi, C., & Fulci, V. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1609834 · Cited by 8
Molecular Diagnosis and Precision Therapeutic Approaches for Telomere Biology Disorders
Perona, R., Iarriccio, L., Pintado‐Berninches, L., Rodríguez-Centeno, J., Manguán-García, C., Garcia, E., López‐Ayllón, B. D., & Sastre, L. (2016) · InTech eBooks · doi:10.5772/65353 · Cited by 12
Jian, Q., Garus, A., & Autexier, C. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad180 · Cited by 10
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology Disorders
Lasho, T., & Patnaik, M. M. (2024) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-023-00719-2 · Cited by 7
TERT and TERC mutations detected in cryptic dyskeratosis congenita suppress telomerase activity
Terada, K., Miyake, K., Yamaguchi, H., Miyake, N., Yamanaka, K., Kojima, S., Ito, E., Inokuchi, K., & Okada, T. (2020) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13176 · Cited by 8
Nouvelles formes de dyskératoses congénitales
Touzot, F., Guen, T. L., de Villartay, J., & Revy, P. (2012) · médecine/sciences · doi:10.1051/medsci/2012286015 · Cited by 10
Domain specific mutations in dyskerin disrupt 3′ end processing of scaRNA13
Nagpal, N., Tai, A., Nandakumar, J., & Agarwal, S. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac706 · Cited by 9
Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors
Zhu, Y., Sun, W., Jiang, X., Bai, R., Luo, Y., Gao, Y., Li, S., Huang, Z., Gong, Y. Q., & Xie, C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281132 · Cited by 9
Dokal, I. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405546-9.00011-x · Cited by 6
Cerrudo, C. S., Gómez, D. L. M., Gomez, D. E., & Ghiringhelli, P. D. (2014) · Journal of Proteome Research · doi:10.1021/pr500956k · Cited by 9
Common presentations and diagnostic approaches
Rezaei, N., de Vries, E., Gambineri, E., Meyts, I., & Haddad, É. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00001-6 · Cited by 7
Advances in understanding telomerase assembly
Klump, B. M., & Schmidt, J. C. (2023) · Biochemical Society Transactions · doi:10.1042/bst20230269 · Cited by 6
Mouse models of testicular germ cell tumors
Carouge, D., & Joseph, H. B. (2012) · InTech eBooks · doi:10.5772/38921 · Cited by 6
TCAB1 prevents nucleolar accumulation of the telomerase RNA to promote telomerase assemblyPreprint
Klump, B. M., Perez, G. I., Patrick, E. M., Adams-Boone, K., Cohen, S. B., Li, H., Yu, K., & Schmidt, J. C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.27.445986 · Cited by 5
Metadata
- Authors
- Zhong, F., Savage, S. A., Shkreli, M., Giri, N., Jessop, L., Myers, T., Chen, R., Alter, B. P., & Artandi, S. E.
- Affiliations
- Stanford Medicine (US)
- National Institutes of Health (US)
- ORCID
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-01-01
- Volume
- 25
- Issue
- 1
- Pages
- 11-16
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC3012932
- OpenAlex
- W2058286861
- Cited by
- 262
- References
- 30
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 12 · 2023: 10 · 2022: 16 · 2021: 13 · 2020: 15 · 2019: 8 · 2018: 20 · 2017: 15 · 2016: 22 · 2015: 20 · 2014: 27 · 2013: 20 · 2012: 24
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leukemia and Lymphoma Society
- Agency for Science, Technology and Research
- National Institutes of Health (CA111691, AG033747)
- National Institute on Aging (AG033747, R01AG033747)
- National Cancer Institute (CA111691, R01CA125453, CA125453, R01CA111691)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- dyskeratosis congenita, Cajal bodies, telomere shortening, nucleolus, compound heterozygosity, cancer susceptibility
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Models, Molecular, Mutation, Pedigree, Sequence Alignment, Molecular Chaperones, Telomerase, Dyskeratosis Congenita, Protein Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.